Orthopaedic News and Research

RSS

Medicare patients may face accessibility crisis to medical care

According to an article in the June issue of the Journal of Bone and Joint Surgery (JBJS), Medicare patients - many who suffer from disabling arthritis of the hip and knee, among other age-related ailments - may end up facing an accessibility crisis to medical care.

2 Jun 2010

Proposed settlement prevents Idaho Orthopaedic Society from engaging in conspiracies to increase fees

The Department of Justice reached a settlement today with the Idaho Orthopaedic Society, an orthopedic practice group and five orthopedists that will prohibit them from conspiring with competing physicians in the Boise, Idaho, area to deny medical care to injured workers and to engage in group boycotts to obtain higher fees.

29 May 2010

Hebrew Union College honors Dr. Dean Lorich with 2010 Roger E. Joseph Prize for humanitarian efforts

Dr. Dean Lorich was honored with the 2010 Roger E. Joseph Prize by Hebrew Union College for his humanitarian efforts in treating victims of the recent Haiti earthquake and in Landstuhl, Germany treating soldiers injured in Iraq and in Afghanistan. The award recognizes individuals making lasting contributions to the causes of human rights.

29 May 2010

Neurological Institute at University Hospitals receives Neuroscience Center of Excellence designation

The Neurological Institute at University Hospitals has been designated as a Neuroscience Center of Excellence (COE), according to the Neuroscience Center of Excellence Survey sponsored by NeuStrategy, Inc., Chicago. It is the first neurological program in Ohio to receive the Stage 4 - Institute designation.

27 May 2010

Kensey Nash granted FDA 510(k) clearance for Meso BioMatrix ECM product

Kensey Nash Corporation, a leading medical technology company that provides innovative resorbable biomaterial technology for a wide range of medical procedures, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration for its second extracellular matrix (ECM) product, the Meso BioMatrix™ product.

27 May 2010

Arthrosurface achieves significant clinical milestone in implant technology

Arthrosurface, Inc., the developer of inlay joint resurfacing systems, announced the achievement of a significant clinical milestone.

25 May 2010

Common misconceptions about general anesthesia

Eight-five per cent of patients who took part in a survey shortly after day surgery said that they had been anxious about receiving a general anaesthetic, according to research in the May issue of the Journal of Advanced Nursing.

21 May 2010

Ansell Healthcare receives "2010 European Surgical Gloves Product Quality Leadership Award"

Based on its recent research on the surgical drapes, gowns and gloves market, Frost & Sullivan presents Ansell Healthcare Europe (Ansell Healthcare) with the "2010 European Surgical Gloves Product Quality Leadership Award" for its Encore® range of surgical gloves. The range consists of multiple products that are customized to support a wide range of surgical procedures including specialty surgery such as orthopaedics and microsurgery.

21 May 2010

Dispelling misconceptions associated with anaesthesia reduce patient anxiety before surgery

20 May 2010

Maternal stretching and meditation keep expecting mothers healthy during pregnancy: AAOS

Perfect for mind and body rejuvenation, yoga uses meditation and aligning movements to encourage fitness and relaxation. This low-impact fitness alternative allows pregnant women to continue an exercise regimen without putting strain on their heart or harming the baby.

18 May 2010

11 leading medical societies support Health Care Truth and Transparency Act of 2010

As the United States prepares to add 32 million more patients to the health care system through health care reform, 11 of the leading medical societies in the country joined together today to publicly support the introduction of the Health Care Truth and Transparency Act of 2010.

14 May 2010

Transdel Pharmaceuticals reports lower net loss of $0.9 million for first-quarter 2010

Transdel Pharmaceuticals, Inc., a specialty pharmaceutical company focused on developing topically administered products using its proprietary transdermal delivery platform, today announced financial results for the quarter ended March 31, 2010. The Company also highlighted recent achievements.

14 May 2010

Folic acid supplement may improve blood flow in young amenorrheic runners

A study led by sports medicine researcher Anne Hoch, D.O. at The Medical College of Wisconsin in Milwaukee has found that oral folic acid may provide a safe and inexpensive treatment to improve vascular function in young female runners who are amenorrheic (not menstruating).

11 May 2010

28% of crashes attributed to cell phone talking, texting while driving

The American Academy of Orthopaedic Surgeons (AAOS) has joined forces with the Orthopaedic Trauma Association (OTA) on a public service announcement (PSA) urging drivers to NEVER text while driving. Simply put, texting is a deadly distraction that can cause accidents, severe orthopaedic injuries or even death. Orthopaedic surgeons not only treat, but want to prevent accidental traumas.

10 May 2010

Osteotech reports overall sequential revenue growth of 117% for first-quarter 2010

Osteotech, Inc., a leader in the emerging field of biologic products for regenerative healing, today reported financial results for the first quarter ended March 31, 2010.

10 May 2010

DJOFL net sales increases 10.3% to $240.1 million for first-quarter 2010

DJO Incorporated a global provider of medical device solutions for musculoskeletal health, vascular health and pain management, today announced financial results for its operating subsidiary, DJO Finance LLC ("DJOFL"), for the first quarter of 2010, ended April 3, 2010.

6 May 2010

Symmetry Medical's first-quarter 2010 revenues up 10.6%

Symmetry Medical Inc., a leading independent provider of products to the global orthopaedic device industry and other medical markets, announced first quarter 2010 financial results for the three-month period ended April 3, 2010.

6 May 2010

Phase II trial: TB-402 demonstrates superior antithrombotic activity to enoxaparin

BioInvent International AB and ThromboGenics NV announce today positive results from their Phase II trial of TB-402. TB-402 is a novel, long acting anticoagulant that is being developed as a single injection for the prevention of venous thromboembolism following orthopaedic surgery.

6 May 2010

Obesity epidemic may be flattening out - still much to be done

The prevalence of childhood obesity might be stabilising in developed countries, but there is still much to be done to combat this major threat to health, according to a Seminar published on Online First and in an upcoming issue of The Lancet.

6 May 2010

ThromboGenics, BioInvent International report positive results from Phase II trial of TB-402 for VTE

ThromboGenics NV and co-development partner BioInvent International announce today positive results from their Phase II trial of TB-402. TB-402 is a novel, long acting anticoagulant that is being developed as a single injection for the prevention of venous thromboembolism (VTE) following orthopaedic surgery.

6 May 2010

Orthopaedic News and Research

Medicare patients may face accessibility crisis to medical care

Proposed settlement prevents Idaho Orthopaedic Society from engaging in conspiracies to increase fees

Hebrew Union College honors Dr. Dean Lorich with 2010 Roger E. Joseph Prize for humanitarian efforts

Neurological Institute at University Hospitals receives Neuroscience Center of Excellence designation

Kensey Nash granted FDA 510(k) clearance for Meso BioMatrix ECM product

Arthrosurface achieves significant clinical milestone in implant technology

Common misconceptions about general anesthesia

Ansell Healthcare receives "2010 European Surgical Gloves Product Quality Leadership Award"

Dispelling misconceptions associated with anaesthesia reduce patient anxiety before surgery

Maternal stretching and meditation keep expecting mothers healthy during pregnancy: AAOS

11 leading medical societies support Health Care Truth and Transparency Act of 2010

Transdel Pharmaceuticals reports lower net loss of $0.9 million for first-quarter 2010

Folic acid supplement may improve blood flow in young amenorrheic runners

28% of crashes attributed to cell phone talking, texting while driving

Osteotech reports overall sequential revenue growth of 117% for first-quarter 2010

DJOFL net sales increases 10.3% to $240.1 million for first-quarter 2010

Symmetry Medical's first-quarter 2010 revenues up 10.6%

Phase II trial: TB-402 demonstrates superior antithrombotic activity to enoxaparin

Obesity epidemic may be flattening out - still much to be done

ThromboGenics, BioInvent International report positive results from Phase II trial of TB-402 for VTE

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News